Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - DEPRECIATION & AMORTIZATION
Depreciation & Amortization HALO - Halozyme Therapeutics, Inc.
81.3 M
LAST VALUE
27.98%
2 YEAR CAGR
82.03%
5 YEAR CAGR
46.69%
10 YEAR CAGR